×

OX40L FUSION PROTEIN FOR THE IMMUNOTHERAPY OF TUMORS OF VETERINARY ANIMALS

  • US 20150191525A1
  • Filed: 11/17/2014
  • Published: 07/09/2015
  • Est. Priority Date: 11/18/2013
  • Status: Active Grant
First Claim
Patent Images

1. An isolated recombinant polypeptide comprising an immunoglobulin domain and a canine OX40L extracellular domain polypeptide, wherein the canine OX40L extracellular domain polypeptide comprises from about amino acid 447 to about amino acid 698 of a polypeptide of SEQ ID NO:

  • 2, or about amino acid 332 to about amino acid 464 of a polypeptide of SEQ ID NO;

    3, or a biological equivalent of each thereof.

View all claims
  • 0 Assignments
Timeline View
Assignment View
    ×
    ×